do you need to be on glp-1 forever Have a Forever? Treatment Duration Explained What happens when you stop

Depression and anxiety are significantly more common in people with COPD compared to the general population, with UK studies reporting prevalence rates of up to 40% in those with moderate to severe disease

Patent expires in India, Canada, and Brazil by 2026, followed by U.S

However, this landscape could shift next year with the anticipated approval of: The oral version of Wegovy for obesity treatment (approved just yesterday) Eli Lillys Orforglipron

PMCID: PMC11840199

A 2026 JAMA Health Forum study of actual pharmacy claims found that once a branded medication hits an initial rejection at the pharmacy counter, the real end-to-end timeline centers around a median of 6 days for multi-day cases, with only 35 percent of prescriptions processed in 1 day

But a more direct route does not answer the underlying question, which is whether the skin-brightening effect is real in the first place